ADVANCED MALIGNANCIES AND HEPATIC IMPAIRMENT

Clinical trials for ADVANCED MALIGNANCIES AND HEPATIC IMPAIRMENT explained in plain language.

Never miss a new study

Get alerted when new ADVANCED MALIGNANCIES AND HEPATIC IMPAIRMENT trials appear

Sign up with your email to follow new studies for ADVANCED MALIGNANCIES AND HEPATIC IMPAIRMENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

Early trial tests cancer drug safety for patients with liver problems

Knowledge-focused Not yet recruiting

This early-stage study aims to understand how a drug called pelabresib is processed in the body of people with advanced cancer who also have liver problems. It will compare drug levels in people with normal liver function to those with moderate or severe liver impairment. The goa…

Matched conditions: ADVANCED MALIGNANCIES AND HEPATIC IMPAIRMENT

Phase: PHASE1 • Sponsor: Novartis Pharmaceuticals • Aim: Knowledge-focused

Last updated Mar 31, 2026 12:11 UTC

ADVANCED MALIGNANCIES AND HEPATIC IMPAIRMENT

Get alerted when new ADVANCED MALIGNANCIES AND HEPATIC IMPAIRMENT trials appear

Early trial tests cancer drug safety for patients with liver problems